He Fu China: Currently, daily operating activities are normal, and there have been no significant fluctuations in production costs and sales.

Hefu China issued an announcement on April 3, stating that the stock price has experienced abnormal fluctuations over 20% for two consecutive trading days on April 2 and April 3, 2026, according to the relevant rules of the Shanghai Stock Exchange. After verification, the company's daily operations are normal, there have been no significant adjustments in the market environment or industry policies, production costs and sales have not fluctuated significantly, internal production and operations are normal, and there have been no major changes in the internal and external operating environment of the company. After a self-examination by the company and verification with the controlling shareholder Hefu Holdings Limited and the indirectly controlled shareholder Cowealth Medical Holding Co., Ltd., it was confirmed that as of the disclosure date of this announcement, there are no major issues affecting the abnormal fluctuations in the company's stock trading price other than the information already disclosed in designated media. There are no other significant undisclosed information related to the company, including but not limited to major asset restructurings, share issuances, significant transactions, business restructuring, share repurchases, equity incentives, bankruptcy reorganization, major business cooperation, introduction of strategic investors, and other major events.